<it>Plasmodium chabaudi chabaudi </it>malaria parasites can develop stable resistance to atovaquone with a mutation in the cytochrome b gene
<p>Abstract</p> <p>Background</p> <p><it>Plasmodium falciparum</it>, has developed resistance to many of the drugs in use. The recommended treatment policy is now to use drug combinations. The atovaquone-proguanil (AP) drug combination, is one of the treatme...
Main Authors: | Alves Ana C, Lopes Dinora, Castro Helena, Neto Zoraima, Afonso Ana, Tomás Ana M, Rosário Virgílio D |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-05-01
|
Series: | Malaria Journal |
Online Access: | http://www.malariajournal.com/content/9/1/135 |
Similar Items
-
The unique structure of the apicoplast genome of the rodent malaria parasite Plasmodium chabaudi chabaudi.
by: Shigeharu Sato, et al.
Published: (2013-01-01) -
Correction: The Unique Structure of the Apicoplast Genome of the Rodent Malaria Parasite Plasmodium chabaudi chabaudi
by: Shigeharu Sato, et al.
Published: (2013-01-01) -
Immunity to malaria using the rodent malaria parasite Plasmodium chabaudi chabaudi AS as a model of the human malaria Plasmodium falciparum
by: Maestre Buitrago, Amanda Elena
Published: (1997) -
Treatment of Plasmodium chabaudi Parasites with Curcumin in Combination with Antimalarial Drugs: Drug Interactions and Implications on the Ubiquitin/Proteasome System
by: Zoraima Neto, et al.
Published: (2013-01-01) -
The B cell response to Plasmodium chabaudi chabaudi : malaria in the mouse model
by: Achtman, Ariel H.
Published: (2003)